Why it's done

Heart transplants are performed when other treatments for heart problems haven't worked, leading to heart failure. In adults, heart failure can be caused by several conditions, including:

  • A weakening of the heart muscle (cardiomyopathy)
  • Coronary artery disease
  • Heart valve disease
  • A heart problem you're born with (congenital heart defect)
  • Dangerous recurring abnormal heart rhythms (ventricular arrhythmias) not controlled by other treatments
  • Amyloidosis
  • Failure of a previous heart transplant

In children, heart failure is most often caused by either a congenital heart defect or a cardiomyopathy.

Another organ transplant may be performed at the same time as a heart transplant (multiorgan transplant) in people with certain conditions at select medical centers. Multiorgan transplants include:

  • Heart-kidney transplant. This procedure may be an option for some people with kidney failure in addition to heart failure.
  • Heart-liver transplant. This procedure may be an option for people with certain liver and heart conditions.
  • Heart-lung transplant. Rarely, doctors may suggest this procedure for some people with severe lung and heart diseases, if the conditions aren't able to be treated by only a heart transplant or lung transplant.

Factors that may affect your eligibility for a heart transplant

A heart transplant isn't the right treatment for everyone. Certain factors may mean you're not a good candidate for a heart transplant. While each case is considered individually by a transplant center, a heart transplant may not be appropriate if you:

  • Are an advanced age that would interfere with the ability to recover from transplant surgery
  • Have another medical condition that could shorten your life, regardless of receiving a donor heart, such as a serious kidney, liver or lung disease
  • Have an active infection
  • Have a recent personal medical history of cancer
  • Are unwilling or unable to make lifestyle changes necessary to keep your donor heart healthy, such as not drinking alcohol or not smoking

Ventricular assist devices

For some people who can't have a heart transplant, another option may be a ventricular assist device (VAD). A ventricular assist device is a mechanical pump implanted in your chest that helps pump blood from the lower chambers of your heart (ventricles) to the rest of your body.

VADs are commonly used as a temporary treatment for people waiting for a heart transplant. These devices are increasingly being used as a long-term treatment for people who have heart failure but aren't eligible for a heart transplant. If a VAD doesn't help your heart, doctors may sometimes consider a total artificial heart — a device that replaces the ventricles of your heart — as an alternative short-term treatment while you're waiting for a heart transplant.

Aug. 18, 2016
  1. What is a heart transplant? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ht. Accessed April 8, 2016.
  2. Mancini D. Indications and contraindications for cardiac transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
  3. Colvin M, et al. OPTN/SRTR annual data report 2014: Heart. American Journal of Transplantation. 2016;16:115.
  4. What is a ventricular assist device? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/vad. Accessed April 7, 2016.
  5. What is a total artificial heart? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/tah. Accessed April 12, 2016.
  6. Flynn B, et al. Heart and lung transplantation. Current Opinion in Anaesthesiology. 2014;27:153.
  7. Goldman L, et al., eds. Cardiac transplantation. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 7, 2016.
  8. Pham MX. Prognosis after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  9. Pham MX. Induction and maintenance of immunosuppressive therapy in cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  10. Pina IL. Rehabilitation after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  11. McKenna WJ. Treatment of amyloid cardiomyopathy. http://www.uptodate.com/home. Accessed April 1, 2016.
  12. What are the risks of heart surgery? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hs/risks. Accessed April 12, 2016.
  13. Barbara Woodward Lips Patient Education Center. Heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  14. Partnering with your transplant team: The patient's guide to transplantation. U.S. Department of Health and Human Services. https://optn.transplant.hrsa.gov/learn/patient-education/. Accessed April 12, 2016.
  15. What every patient needs to know. United Network for Organ Sharing. http://www.transplantliving.org/community/patient-resources/publications/. Accessed April 13, 2016.
  16. Diet and exercise. United Network for Organ Sharing: Transplant living. http://www.transplantliving.org/after-the-transplant/staying-healthy/diet-and-exercise/. Accessed April 13, 2016.
  17. Eisen HJ. Prevention and treatment of cardiac allograft vasculopathy. http://www.uptodate.com/home. Accessed April 13, 2016.
  18. Topilsky Y, et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012;125:708.
  19. Transplant gives recipient chance to re-establish priorities. Mayovox. August 1988;39:1.
  20. Heart transplant program to resume in fall of 1986. Mayovox. January 1986;37:1.
  21. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 8, 2016.
  22. Matsuo Y, et al. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. The Journal of Heart and Lung Transplantation. 2013;32:784.
  23. Gertz MA, et al. Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology. 2015;12:91.
  24. Williams BA, et al. Heart failure and heart rhythm disorders. In: Current Diagnosis & Treatment: Geriatrics. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com. Accessed April 21, 2016.
  25. Guddetti RR, et al. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy. Circulation: Cardiovascular Imaging. 2015;8:e002636.
  26. Yancy CW, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62: e147.
  27. Yip DS (expert opinion). Mayo Clinic, Jacksonville, Fla. May 24, 2016.
  28. Medical practice report: Heart transplant. Press Ganey. http://www.pressganey.com/. Accessed May 24, 2016.
  29. Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report — 2015; focus theme: Early graft failure. The Journal of Heart and Lung Transplantation. 2015;34:1244.

Connect with others

News, connections and conversations for your health

Recent posts